chr16-29813939-C-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4BP6

The NM_145239.3(PRRT2):​c.879+6C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,570,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000013 ( 0 hom. )

Consequence

PRRT2
NM_145239.3 splice_region, intron

Scores

3
4
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.346

Publications

2 publications found
Variant links:
Genes affected
PRRT2 (HGNC:30500): (proline rich transmembrane protein 2) This gene encodes a transmembrane protein containing a proline-rich domain in its N-terminal half. Studies in mice suggest that it is predominantly expressed in brain and spinal cord in embryonic and postnatal stages. Mutations in this gene are associated with episodic kinesigenic dyskinesia-1. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
MVP-DT (HGNC:56029): (MVP divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.268013).
BP6
Variant 16-29813939-C-A is Benign according to our data. Variant chr16-29813939-C-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 468621.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRRT2NM_145239.3 linkc.879+6C>A splice_region_variant, intron_variant Intron 2 of 3 ENST00000358758.12 NP_660282.2 Q7Z6L0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRRT2ENST00000358758.12 linkc.879+6C>A splice_region_variant, intron_variant Intron 2 of 3 1 NM_145239.3 ENSP00000351608.7 Q7Z6L0-1
ENSG00000280893ENST00000609618.2 linkn.879+6C>A splice_region_variant, intron_variant Intron 2 of 5 5 ENSP00000476774.2 A0A0G2JLL6

Frequencies

GnomAD3 genomes
AF:
0.000105
AC:
16
AN:
152108
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000233
AC:
5
AN:
214276
AF XY:
0.0000174
show subpopulations
Gnomad AFR exome
AF:
0.000318
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000134
AC:
19
AN:
1418130
Hom.:
0
Cov.:
35
AF XY:
0.00000998
AC XY:
7
AN XY:
701338
show subpopulations
African (AFR)
AF:
0.000591
AC:
19
AN:
32142
American (AMR)
AF:
0.00
AC:
0
AN:
39276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23276
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79406
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51858
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5550
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1089086
Other (OTH)
AF:
0.00
AC:
0
AN:
58370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000105
AC:
16
AN:
152226
Hom.:
0
Cov.:
32
AF XY:
0.000108
AC XY:
8
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41530
American (AMR)
AF:
0.00
AC:
0
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67998
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000132
Hom.:
0
Bravo
AF:
0.000166
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Dec 13, 2017
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 21, 2025
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Episodic kinesigenic dyskinesia Uncertain:1
Dec 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change falls in intron 2 of the PRRT2 gene. It does not directly change the encoded amino acid sequence of the PRRT2 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs201887920, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with PRRT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 468621). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
18
DANN
Uncertain
1.0
Eigen
Pathogenic
0.72
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.24
.;T
M_CAP
Pathogenic
0.38
D
MetaRNN
Benign
0.27
T;T
MetaSVM
Uncertain
-0.24
T
PhyloP100
0.35
PROVEAN
Benign
2.7
.;N
REVEL
Uncertain
0.29
Sift
Pathogenic
0.0
.;D
Polyphen
1.0
D;D
Vest4
0.38
MutPred
0.29
Loss of glycosylation at S295 (P = 0.0013);Loss of glycosylation at S295 (P = 0.0013);
MVP
0.94
ClinPred
0.090
T
GERP RS
2.2
PromoterAI
-0.030
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201887920; hg19: chr16-29825260; API